Fig. 5: Outcomes according to the pattern of progression disease; comparing patients with progression disease only by serum-free light chain (sFLC-PD) and patients with urine M-protein progression disease, measured by urine electrophoresis (urine PD), with or without sFLC-PD. | Blood Cancer Journal

Fig. 5: Outcomes according to the pattern of progression disease; comparing patients with progression disease only by serum-free light chain (sFLC-PD) and patients with urine M-protein progression disease, measured by urine electrophoresis (urine PD), with or without sFLC-PD.

From: Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresis

Fig. 5

A Median Second Progression-Free Survival. B Median Overall survival from first relapse. CI confidence interval, PD progressive disease, sFLC serum-free light chain, PFS progression-free survival, OS overall survival.

Back to article page